GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Argent Biopharma RGT.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.02

-13.64%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Argent Biopharma — daily ASX:RGT

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Argent Biopharma on TradingView ↗
Market value
A$1.1m
Last close × shares
Volume
350.4k
Shares, 9 Nov 2026

About Argent Biopharma

Its shares trade on ASX under the ticker RGT.AX. It has been listed since 21 December 2006. In the fiscal year to 30 June 2026, it reported revenue of A$161,187 and a net loss of A$7.7m. At that date it held total assets of A$1.3m and shareholders' equity of −A$9.4m.

MGC Pharmaceuticals Ltd. engages in the production of medical marijuana. The company is headquartered in Perth, Western Australia. The company went IPO on 2006-12-21. The firm is primarily focused on the development and supply of standardized phytomedicines to patients globally. The company has three clinical projects, as well as a pipeline of therapies: CimetrA, a Phase III symptomatic treatment for early COVID-19; CannEpil, a Phase IIb cannabis-based therapy for drug-resistant Epilepsy; CogniCann, in a Phase II trial for symptomatic relief of Dementia, and Irnican, a preclinical medicine to be used for treatment for Glioblastoma. The firm is focused on the ArtemiC range of products, and its cannabinoid products are primarily distributed within Australia, the United Kingdom and South America. The company has a product offering targeting two medical conditions, which include epilepsy and dementia. The firm's wholly owned subsidiaries include MGC Pharma (UK) Limited, MGC Research (Aus) Pty Ltd, and Medicinal Cannabis Clinics Pty Ltd.

Figures and description from our data supplier, not checked against the company's own report.

More about Argent Biopharma →

Latest on Argent Biopharma

Our reporting

We have not reported on Argent Biopharma yet.

Next results

3 Mar 2027

Due on 3 Mar 2027.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Argent Biopharma's ticker?

Argent Biopharma trades as RGT.AX on ASX, under ISIN AU0000326647.

What was Argent Biopharma's last closing price?

0.02 on 9 Nov 2026. The figure is in AUD and is never converted.

When does Argent Biopharma next report results?

Results are expected on 3 Mar 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.